These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9870852)

  • 1. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.
    Fitzgibbons PL; Henson DE; Hutter RV
    Arch Pathol Lab Med; 1998 Dec; 122(12):1053-5. PubMed ID: 9870852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coexistence of atypical intraductal hyperplasias with breast carcinoma.
    Bogdan F; Gîrniţă L; Florescu M; Simionescu C; Crăiţoiu S; Comănescu V
    Rom J Morphol Embryol; 1998; 44(1-4):65-71. PubMed ID: 15678845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast lesions with moderate and high risk of invasive breast cancer--incidence and some particularities].
    Ivanov I; Baĭchev G; Betova T
    Akush Ginekol (Sofiia); 2008; 47(5):17-21. PubMed ID: 19230257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of fibroadenoma of the breast.
    Kuijper A; Mommers EC; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2001 May; 115(5):736-42. PubMed ID: 11345838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomas of the breast. A histologic spectrum including atypical hyperplasia and carcinoma in situ.
    McKinney CD; Fechner RE
    Pathol Annu; 1995; 30 Pt 2():137-78. PubMed ID: 8570274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic considerations in the high-risk breast patient.
    Simmons R; Serafin D; McCarty K
    Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fiberoptic ductoscopy-guided intraductal biopsy improve the diagnosis of nipple discharge.
    Ling H; Liu GY; Lu JS; Love S; Zhang JX; Xu XL; Xu WP; Shen KW; Shen ZZ; Shao ZM
    Breast J; 2009; 15(2):168-75. PubMed ID: 19292803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of high-risk breast lesions and ductal carcinoma in situ.
    Sewell CW
    Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of large-caliber stereotactic biopsies in nonpalpable breast lesions.
    Deschryver K; Radford DM; Schuh ME
    Semin Diagn Pathol; 1999 Aug; 16(3):224-34. PubMed ID: 10490199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
    Mridha AR; Iyer VK; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignancy risk in some benign mammary lesions].
    Muscă S; Strat L; Maxim R; Negură A; Florea A; Slătineanu S; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):375-8. PubMed ID: 14755944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
    Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F
    Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of the breast in children, adolescents, and young adults.
    Dehner LP; Hill DA; Deschryver K
    Semin Diagn Pathol; 1999 Aug; 16(3):235-47. PubMed ID: 10490200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological pattern of benign breast disease as a risk factor for invasive breast cancer.
    Bianchi S; del Turco MR; Simoncini R; Distante V; Russo A; Palli D
    Cancer Detect Prev; 1992; 16(1):17-9. PubMed ID: 1551133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.